Pharmacy and Therapeutics Committee Updates

(From the August 2018 Issue of MedStat)

The following actions were taken at the 7/5/18 Pharmacy & Therapeutics Committee meeting:

  • Burosumab (Crysvita) was ADDED to formulary with a requirement of prior authorization to initiate therapy  
  • The Chemotherapy Drug Cards were APPROVED
  • The Catheter-Directed Thrombolysis Policy was APPROVED
  • Controlled Substance Storage Policy was APPROVED